Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Smoking 1Oligodendroglioma 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Glioma 1Astrocytoma 1

Interventions

Cyclophosphamide 4Rituximab 3ibrutinib 2Peripheral Blood Stem Cell Transplantation 2venetoclax 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1ibritumomab tiuxetan 1fludarabine phosphate 1fludarabine 1brexucabtagene autoleucel 1acalabrutinib 1Vincristine 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Sirolimus 1Ribavirin 1Precision Medicine 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Pemetrexed 1NVP-BKM120 1Methotrexate 1Loratadine 1Immunohistochemistry 1Immunoenzyme Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, Mantle-Cell × Practice Guidelines as Topic × Clear all
NCT03219047 2023-07-27

Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
1 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡